跳至主要内容
临床试验/CTRI/2024/02/063037
CTRI/2024/02/063037招募中3 期

The Efficacy and Safety of Sugammadex and Neostigmine for reversing Rocuronium induced neuromuscular blockade in Obese patients - Nill

Dr Sumedha Mehta0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Obese patients
  • 2) Obese patients undergoing general anesthesia requiring muscle relaxants.

排除标准

  • 1)Difficult Airway
  • 2) Neuromuscular disorder that could impair neuromuscular blockade.
  • 3) Significant renal or hepatic dysfunction.
  • 4) Family history of malignant hyperthermia.
  • 5) Patients receiving medication (for example: magnesium, anticonvulsants, aminoglycosides) expected to interfere with the muscle relaxant.
  • 6) Patients requiring post -operative ventilator support.
  • 7) Patients already intubated or tracheostomized.
  • 8) Patient refusal.
  • 9) Pregnant or lactating women.
  • 10) Any allergy to study drugs

研究者

发起方
Dr Sumedha Mehta

相似试验